Page 466 - Feline Cardiology

Index 491

Primary (or “essential”) hypertension, 330 diagnostic testing, 389–390 Pulmonary venous congestion, lateral and
Prinivil (lisinopril), 458 echocardiography, 389–390 ventrodorsal views of cat with
indications, dosage, available sizes, 453 differential diagnosis, 389 evidence of, 44
PR interval, 217 etiology, pathophysiology, and gross Pulmonary venous distension
ProBanthine (propantheline), 458 pathology, 388–389 HCM and, 126
ProBNP. See NT-proBNP history, chief complaint, and physical heart failure and, 167
Procainamide, 459 examination, 389 Pulmonary venous flow
indications, dosage, available sizes, 459 outcome and prognosis, 390 measuring, 65
injectable, ventricular tachyarrhythmias radiographic changes and, 46 by PW Doppler, diastolic dysfunction
and, 289 signalment, 389 and, 138
ventricular tachcardia and, 234 treatment, 390 Pulmonary vessels, radiographic
Procan (procainamide), 459 Pulmonary artery flow, echocardiographic assessment of, 43
indications, dosage, available sizes, 459 recording of, 59 Pulmonic stenosis, 85, 98, 99
Prohormone (pre-proBNP), heart disease Pulmonary artery stenosis, 98, 99 Pulse deficit, PVCs and, 230
screening and, 282 Pulmonary blood flow, 388 Pulsed-wave Doppler, 52
Pro-left ventricular hypertrophy Pulmonary blood flow-associated Pulsed-wave Doppler echocardiograms
genotypes, in HCM, 109 pulmonary hypertension, obtained at aorta with correctly
PromAce (acepromazine), 459 388–389 positioned calipers for
indications, dosage, available sizes, 442 Pulmonary capillary wedge pressure, measuring PEP and ET, 59
Pronestyl (procainamide), 459 normal values, feline, inside covers obtained at pulmonary artery from
indications, dosage, available sizes, 459 Pulmonary edema normal cat, 53
Propantheline in cats with CHF due to HCM, 259 Pulsed-wave Doppler echocardiography
indications, dosage, available sizes, 459 in cats with severe HCM, 110 diastolic dysfunction diagnosed with,
second-degree AV blocks and, 238 congestive heart failure and, 272 138
Prophylactic anticoagulant therapy, HCM hypoxemia and, 291 diastolic function assessment, HCM
and, 164 left atrial dilation/left heart failure and, and, 137–139
Propofol 279 Pulsed-wave Doppler TDI, 64
anesthesia, for cardiac patient, 414t left-sided congestive heart failure and, cardiac diseases and, 281
induction of, 416 260, 261, 266–267 limitations with, 65
Propranolol, 156, 157 lung radiopacity and, 46 waves occurring during ventricular
atrial tachycardia and, 224 in Maine coon cat with severe HCM, 113 systole and, 140
indications, dosage, available sizes, 459 pleural effusion comorbid with, in Pulseless electrical activity, 29, 237
tetralogy of Fallot and, 99 CHF, 276 Pulsus paradoxus, acquired pericardial
ventricular tachycardia and, 234, 236, refractory congestive heart failure and, diseases and, 345
237 294 Purring, atrial fibrillation misdiagnosed
Prospective gating, diastolic function thoracic radiographs of cat with, 275 due to ECG manifestation of,
assessment with cMRI and, 146 Pulmonary hemorrhage, lung radiopacity 225, 226
Prostacyclin, role of in platelets and and, 46 PVCs. See Premature ventricular
thromboembolism, 313 Pulmonary hypertension. See Pulmonary complexes
Prostaglandin arterial hypertension PVR. See Pulmonary vascular resistance
role of in platelet function and Pulmonary thromboembolism, 383–387 P waves, 217
thromboembolism, 313 characteristics of, 383 atrial tachycardia and, 223
treatment for pulmonary hypertension conditions identified in association second-degree AV block and, 237
using, 390 with, in cats, 384t Pyelonephritis, 370
Prothrombin time diagnostic testing, 385–387
arterial thromboembolism and, 311 advanced testing, 386–387 Q
warfarin and monitoring with, 317 initial tests, 385–386 QRS complexes, 56, 217
Pseudohypertrophy, HCM vs., 121 differential diagnosis, 385 atrial fibrillation and, 225
Pseudonormal diastolic heart failure etiology and pathophysiology, 383–384 atrial standstill (silent atrium) and,
pattern, Doppler history and chief complaint, 384–385 243
echocardiographic assessment outcome and prognosis, 387 atrial tachycardia and, 223
of, 137 physical examination, 385 bundle branch blocks and, 242
Pseudonormalization phenomenon, 62 radiographic findings for, 48 electrical alternans and, 249
Pseudonormal phase, diastolic signalment, 384 Mobitz type II second-degree AV block
dysfunction and, 138 thoracic radiograph of adult cat with, and, 238
Pseudo-SAM, 121 386 pericardial effusions and, 346
PTE. See Pulmonary thromboembolism treatment, 387 premature ventricular complexes and,
Pulmonary arterial hypertension, 387–390 Pulmonary vascular resistance, 388 230, 231
congestive heart failure leading to, 297 Pulmonary vein velocity, diastolic heart second-degree AV block and, 237
defined, 387 failure and, 137 third-degree AV block and, 239, 240